Image may be NSFW.
Clik here to view.
Clik here to view.
New therapies enlist immune cells to attack tumour cells, or make them more effective © ShutterstockDrug
firms are investing heavily in clinical trials and collaborations
as they seek to capitalise on the potential of cancer therapies that enlist or enhance our immune systems’ ability to fight tumours.
The most optimistic estimates say immuno-oncology drugs could be
worth up to $35 billion (£21 billion) a year over the next decade.
A host of companies are chasing this prize, and unleashed a flood of clinical trial data at the American Society of Clinical Oncology (ASCO) meeting held in Chicago in early June.read at
http://www.rsc.org/chemistryworld/2014/06/pharma-vies-unleash-immune-system-power-cancer
Filed under: Uncategorized Tagged: immune, rsc Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
